Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT04341142
Active, not recruiting Not applicable

Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER

NCT04341142 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2020-04-10
Last updated
2024-05-22

Condition(s) studied

CoV2 Positive Caregivers

Investigational drug(s) / intervention(s)

Serological tests will be applied on patients blood sampling

Serological tests will be applied on patients blood sampling: Application of tests on patients' serum

Study summary

Covid-SER is a prospective multi-center study for the evaluation of diagnostic performance of available serological tests

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Seropositive caregivers screened for anti-SARS CoV2 antibodies during their consultation at the occupational medicine of HCL. * Age: ≥ 18 years old * Persons having given their written consent and accepting a follow-up every 6 months for 24 months, followed by a final visit at 36 months. * Persons affiliated to a social security scheme or beneficiary of such a scheme. Exclusion Criteria: * Pregnant or lactating woman

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hôpital Lyon Sud,Sainte Eugénie bat 4M,5, Chemin du Grand Revoyet Pierre-Bénite France

More Hospices Civils de Lyon trials in France

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04341142 on ClinicalTrials.gov ↗ ← All trials in France